SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Cost‐effectiveness of prostate cancer chemoprevention
10 references·0 citing·45 second hop
Cost‐effectiveness of prostate cancer chemoprevention (2008)Cost‐effectiveness of prostate cancer che…Utilities For Prostate Cancer Health States in Men Aged 60 and Older (2005)Utilities For Prostate Cancer…What Is the Price of Life and Why Doesn't It Increase at the Rate of Inflation? (2003)What Is the Price of Life and…Patient and Community Preferences for Outcomes in Prostate Cancer (2003)Patient and Community Prefere…Willingness to Pay for a Quality-adjusted Life Year (2000)Willingness to Pay for a Qual…Utility Scores for Chronic Conditions in a Community-Dwelling Population (1999)Utility Scores for Chronic Co…Gains in Life Expectancy from Medical Interventions — Standardizing Data on Outcomes (1998)Gains in Life Expectancy from…Guidelines for Pharmacoeconomic Studies (1997)Guidelines for Pharmacoeconom…Cost-Effectiveness in Health and Medicine (1996)Cost-Effectiveness in Health …Tentative guidelines for using clinical and economic evaluations revisited. (1993)Tentative guidelines for usin…Guidelines for pharmacoeconomic studies. (1992)Guidelines for pharmacoeconom…Utility approach to measuring health-related quality of life (1987)A Clinician's Guide to Cost-Effectiveness Analysis (1990)How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)Cost-effectiveness ratios: in a league of their own (1994)Threshold Analysis and Programs for Prevention of HIV Infection (1995)The impact of using different costing methods on the results of an economic evaluation of cardiac care: microcosting vs gross‐costing approaches (2008)An Assessment of Clinically Useful Measures of the Consequences of Treatment (1988)Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine (1996)The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine (1996)Estimating the cost-effectiveness of 54 weeks of infliximab for rheumatoid arthritis (2002)Medical Economics and the Assessment of Value in Cardiovascular Medicine: Part I (2002)Reducing the costs of phase III cardiovascular clinical trials (2005)Contingent Valuation: Is Some Number Better than No Number? (1994)Cost-of-illness studies: concepts, scopes, and methods (2014)Thresholds for the cost–effectiveness of interventions: alternative approaches (2014)Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold (2015)Social Security Bulletin (2018)Protected Values and Omission Bias (1999)Interpreting the Results of Cost-Effectiveness Studies (2008)What Does the Value of Modern Medicine Say About the $50,000 per Quality-Adjusted Life-Year Decision Rule? (2008)A systematic review of the cost and cost-effectiveness studies of immune checkpoint inhibitors (2018)Multi-Attribute Health Status Classification Systems (1995)The construction of preference. (1995)Whose quality of life? A commentary exploring discrepancies between health state evaluations of patients and the general public (2003)Is Proton Beam Therapy Cost Effective in the Treatment of Adenocarcinoma of the Prostate? (2007)Cost-Effectiveness Analysis of Stereotactic Body Radiation Therapy Versus Intensity-Modulated Radiation Therapy: An Emerging Initial Radiation Treatment Option for Organ-Confined Prostate Cancer (2012)Cost-effectiveness analysis of intensity-modulated radiation therapy with normal and hypofractionated schemes for the treatment of localised prostate cancer (2016)The utility of different health states as perceived by the general public (1978)Measurement of health state utilities for economic appraisal (1986)The Beaver Dam Health Outcomes study (1993)Health Utilities Index Mark 3 (2000)The Utility of Health States After Stroke (2001)The Impact of Chronic Hepatitis B on Quality of Life: A Multinational Study of Utilities from Infected and Uninfected Persons (2008)Multiattribute and Single-Attribute Utility Functions for the Health Utilities Index Mark 3 System (2002)Comparison of EQ-5D, HUI, and SF-36-derived societal health state values among Spine Patient Outcomes Research Trial (SPORT) participants (2005)A Review and Meta-Analysis of Prostate Cancer Utilities (2007)Measuring Preferences for Cost-Utility Analysis (2007)The Expected Utility Model: Its Variants, Purposes, Evidence and Limitations (2007)Theory of games and economic behavior (2019)Pharmacoeconomic Analyses Using Discrete Event Simulation (2005)Risk of bias in model-based economic evaluations: the ECOBIAS checklist (2015)EQ-5D in Central and Eastern Europe: 2000–2015 (2016)EQ-SD: a measure of health status from the EuroQol Group (2001)Innovation in the pharmaceutical industry: New estimates of R&D costs (2016)Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses (2016)
this work references cited by second hop

References

  • 1996Cost-Effectiveness in Health and Medicine7,192 cited
  • 2000Willingness to Pay for a Quality-adjusted Life Year849 cited
  • 2003What Is the Price of Life and Why Doesn't It Increase at the Rate of Inflation?588 cited
  • 1998Gains in Life Expectancy from Medical Interventions — Standardizing Data on Outcomes334 cited
  • 1999Utility Scores for Chronic Conditions in a Community-Dwelling Population252 cited
  • 1997Guidelines for Pharmacoeconomic Studies233 cited
  • 1992Guidelines for pharmacoeconomic studies.224 cited
  • 2005Utilities For Prostate Cancer Health States in Men Aged 60 and Older169 cited
  • 2003Patient and Community Preferences for Outcomes in Prostate Cancer119 cited
  • 1993Tentative guidelines for using clinical and economic evaluations revisited.113 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work